Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Wayne Jones

Psychiatry Richardson, TX Medical Doctor

NPI 1457470528 CMS profile 293040

375 Municipal Dr Ste 224, Richardson, TX 75080

Open in the dashboard

General payments

$3,999

212 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Wayne Jones of Richardson, TX is reported in the CMS Open Payments database as having received $3,999 across 212 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $42 3
2022 General $472 28
2021 General $1,703 76
2020 General $592 34
2019 General $1,190 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wayne Jones
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Wayne Jones were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Wayne Jones Psychiatry median Middle half National median
2019 $1,190 $184 $59–$605 $163
2020 $592 $119 $36–$372 $114
2021 $1,703 $143 $43–$576 $132
2022 $472 $153 $50–$590 $149
2023 $42 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Supernus Pharmaceuticals, Inc. $437 7 payments
  2. Ironshore Pharmaceuticals Inc. $413 24 payments
  3. Jazz Pharmaceuticals Inc. $361 11 payments
  4. Janssen Pharmaceuticals, Inc $356 12 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $334 19 payments
  6. Avanir Pharmaceuticals, Inc. $246 14 payments
  7. Allergan Inc. $244 9 payments
  8. Arbor Pharmaceuticals, Inc. $197 36 payments
  9. Eisai Inc. $197 10 payments
  10. Validus Pharmaceuticals LLC $159 3 payments
  11. Other $1,054 67 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $3,999 212 payments
Products named General payments · program years 2019–2023
  1. QELBREE $437 7 payments
  2. SPRAVATO $344 11 payments
  3. JORNAY PM $344 20 payments
  4. TRINTELLIX $252 14 payments
  5. NUEDEXTA $246 14 payments
  6. VRAYLAR $244 9 payments
  7. SUNOSI $224 9 payments
  8. Dayvigo $197 10 payments
  9. Equetro $159 3 payments
  10. APLENZIN $157 11 payments
  11. Other $1,797 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record